Comprehensive Review of CBD's Potential for Brain Disorders
Review of 170 articles maps CBD's anti-inflammatory and neuroprotective mechanisms, proposing metabolomics as the next frontier.
Quick Facts
What This Study Found
CBD antagonizes pro-inflammatory cytokines, regulates oxidative stress, downregulates TNF-alpha, restores BDNF and serotonin across neurological disorders.
Key Numbers
170 articles (41% of screened); TNF-alpha downregulation, BDNF restoration, serotonin recovery
How They Did This
Narrative review of 170 articles (41% of screened) from PubMed, Web of Science, and Scopus.
Why This Research Matters
Maps CBD mechanisms across brain disorders in one reference; proposes metabolomics for personalized therapy.
The Bigger Picture
Translating preclinical CBD findings into clinical treatments remains the challenge.
What This Study Doesn't Tell Us
Narrative review. Mostly preclinical. No new data. Breadth limits depth.
Questions This Raises
- ?Can metabolomics predict CBD response?
- ?Which conditions have strongest clinical CBD evidence?
Trust & Context
- Key Stat:
- 170 articles reviewed across neurological and neuropsychiatric conditions
- Evidence Grade:
- Broad narrative review of mostly preclinical evidence.
- Study Age:
- Published in 2024.
- Original Title:
- A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.
- Published In:
- Journal of cannabis research, 6(1), 14 (2024)
- Database ID:
- RTHC-05601
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
How does CBD fight brain inflammation?
By antagonizing cytokines, downregulating TNF-alpha, and restoring BDNF and serotonin.
What is metabolomics?
Study of metabolic small molecules that could predict CBD treatment response.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05601APA
Omotayo, Oluwadara Pelumi; Lemmer, Yolandy; Mason, Shayne. (2024). A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.. Journal of cannabis research, 6(1), 14. https://doi.org/10.1186/s42238-024-00222-2
MLA
Omotayo, Oluwadara Pelumi, et al. "A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.." Journal of cannabis research, 2024. https://doi.org/10.1186/s42238-024-00222-2
RethinkTHC
RethinkTHC Research Database. "A narrative review of the therapeutic and remedial prospects..." RTHC-05601. Retrieved from https://rethinkthc.com/research/omotayo-2024-a-narrative-review-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.